- Home
- PMVP vs VATE Comparison
PMVP vs VATE Comparison
Compare PMVP & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- VATE
- Stock Information
- Founded
- PMVP 2013
- VATE 1994
- Country
- PMVP United States
- VATE United States
- Employees
- PMVP N/A
- VATE N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- VATE Metal Fabrications
- Sector
- PMVP Health Care
- VATE Industrials
- Exchange
- PMVP Nasdaq
- VATE Nasdaq
- Market Cap
- PMVP 55.1M
- VATE 98.2M
- IPO Year
- PMVP 2020
- VATE 1996
- Fundamental
- Price
- PMVP $1.15
- VATE $5.45
- Analyst Decision
- PMVP Strong Buy
- VATE
- Analyst Count
- PMVP 1
- VATE 0
- Target Price
- PMVP $5.00
- VATE N/A
- AVG Volume (30 Days)
- PMVP 278.5K
- VATE 18.5K
- Earning Date
- PMVP 08-07-2025
- VATE 08-06-2025
- Dividend Yield
- PMVP N/A
- VATE N/A
- EPS Growth
- PMVP N/A
- VATE N/A
- EPS
- PMVP N/A
- VATE N/A
- Revenue
- PMVP N/A
- VATE $1,066,100,000.00
- Revenue This Year
- PMVP N/A
- VATE N/A
- Revenue Next Year
- PMVP N/A
- VATE N/A
- P/E Ratio
- PMVP N/A
- VATE N/A
- Revenue Growth
- PMVP N/A
- VATE N/A
- 52 Week Low
- PMVP $0.81
- VATE $3.25
- 52 Week High
- PMVP $1.82
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- PMVP 57.96
- VATE 49.75
- Support Level
- PMVP $0.96
- VATE $5.04
- Resistance Level
- PMVP $1.14
- VATE $5.37
- Average True Range (ATR)
- PMVP 0.07
- VATE 0.24
- MACD
- PMVP -0.00
- VATE 0.06
- Stochastic Oscillator
- PMVP 65.28
- VATE 89.66
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.